ABLIVA AB
5Patents
5Active
5Granted
51Portfolio score
Filing activity: Apr 8, 2015 → Sep 14, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11565998B2 | Succinate prodrug, compositions containing the succinate prodrug and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US12310940B2 | Cell-permeable succinate compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US11147789B2 | Cell-permeable succinate compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US10857150B2 | Use of sanglifehrin macrocyclic analogues as anticancer compounds | Chemistry; Metallurgy | 0 | Active |
| US12162824B2 | Succinate prodrug, compositions containing the succinate prodrug and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.